American Journal of Epidemiology Vol. 154, No. 9 : 854-864
Copyright © 2001 by The Johns Hopkins University School of Hygiene and Public Health
PRACTICE OF EPIDEMIOLOGY |
Performance of Comorbidity Scores to Control for Confounding in Epidemiologic Studies using Claims Data
1 Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital and Harvard Medical School, Boston, MA.
2 Department of Epidemiology, Harvard School of Public Health, Boston, MA.
3 Pharmacare, Ministry of Health, British Columbia, Canada.
4 Department of Preventive Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA.
Comorbidity is an important confounder in epidemiologic studies. The authors compared the predictive performance of comorbidity scores for use in epidemiologic research with administrative databases. Study participants were British Columbia, Canada, residents aged 
65 years who received angiotensin-converting enzyme inhibitors or calcium channel blockers at least once during the observation period. Six scores were computed for all 141,161 participants during the baseline year (1995–1996). Endpoints were death and health care utilization during a 12-month follow-up (1996–1997). Performance was measured by using the c statistic ranging from 0.5 for chance prediction of outcome to 1.0 for perfect prediction. In logistic regression models controlling for age and gender, four scores based on the International Classification of Diseases, Ninth Revision (ICD-9) generally performed better at predicting 1-year mortality (c = 0.771, c = 0.768, c = 0.745, c = 0.745) than medication-based Chronic Disease Score (CDS)-1 and CDS-2 (c = 0.738, c = 0.718). Number of distinct medications used was the best predictor of future physician visits (R2 = 0.121) and expenditures (R2 = 0.128) and a good predictor of mortality (c = 0.745). Combining ICD-9 and medication-based scores improved the c statistics (1.7% and 6.2%, respectively) for predicting mortality. Generalizability of results may be limited to an elderly, predominantly White population with equal access to state-funded health care.
comorbidity; confounding factors (epidemiology); databases; epidemiologic studies; health services
Abbreviations: CDS, Chronic Disease Score; ICD-9, International Classification of Diseases, Ninth Revision; OR, odds ratio; RR, relative risk; SD, standard deviation
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  C. M Kelly, D. N Juurlink, T. Gomes, M. Duong-Hua, K. I Pritchard, P. C Austin, and L. F Paszat Selective serotonin reuptake inhibitors and breast cancer mortality in women receiving tamoxifen: a population based cohort study BMJ, February 8, 2010; 340(feb08_1): c693 - c693. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. A H Dhabali and R. Awang A medication-estimated health status measure for predicting primary care visits: the Long-Term Therapeutic Groups Index Health Policy Plan., November 18, 2009; (2009) czp051v1. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Nosyk, Y. C. MacNab, H. Sun, B. Fischer, D. C. Marsh, M. T. Schechter, and A. H. Anis Proportional Hazards Frailty Models for Recurrent Methadone Maintenance Treatment Am. J. Epidemiol., September 15, 2009; 170(6): 783 - 792. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. C. ANG, N. TAHIR, H. HANIF, Y. TONG, and S. A. IBRAHIM African Americans and Whites Are Equally Appropriate to be Considered for Total Joint Arthroplasty J Rheumatol, September 1, 2009; 36(9): 1971 - 1976. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Avorn and S. Schneeweiss Immunosuppressants, mortality, and risk of cancer BMJ, July 6, 2009; 339(jul03_1): b1645 - b1645. [Full Text]
|
|
|
|
 |
|
 K. Johnell, G. R. Weitoft, and J. Fastbom Sex Differences in Inappropriate Drug Use: a Register-Based Study of Over 600,000 Older People Ann. Pharmacother., July 1, 2009; 43(7): 1233 - 1238. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Perez, J. Moisan, C. Sirois, P. Poirier, and J.-P. Gregoire Initiation of insulin therapy in elderly patients taking oral antidiabetes drugs Can. Med. Assoc. J., June 23, 2009; 180(13): 1310 - 1316. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. M. Bell, W. V. Hatch, H. D. Fischer, G. Cernat, J. M. Paterson, A. Gruneir, S. S. Gill, S. E. Bronskill, G. M. Anderson, and P. A. Rochon Association Between Tamsulosin and Serious Ophthalmic Adverse Events in Older Men Following Cataract Surgery JAMA, May 20, 2009; 301(19): 1991 - 1996. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. S. Adams, F. Zhang, R. F. LeCates, A. J. Graves, D. Ross-Degnan, D. Gilden, T. J. McLaughlin, C. Lu, C. M. Trinacty, and S. B. Soumerai Prior Authorization for Antidepressants in Medicaid: Effects Among Disabled Dual Enrollees Arch Intern Med, April 27, 2009; 169(8): 750 - 756. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Zhang, A. S. Adams, D. Ross-Degnan, F. Zhang, and S. B. Soumerai Effects of Prior Authorization on Medication Discontinuation Among Medicaid Beneficiaries With Bipolar Disorder Psychiatr Serv, April 1, 2009; 60(4): 520 - 527. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Schneeweiss, A. R. Patrick, A. Pedan, L. Varasteh, R. Levin, N. Liu, and W. H. Shrank The Effect Of Medicare Part D Coverage On Drug Use And Cost Sharing Among Seniors Without Prior Drug Benefits Health Aff., March 1, 2009; 28(2): w305 - w316. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. K Choudhry, B. Zagorski, J. Avorn, R. Levin, K. Sykora, A. Laupacis, and M. Mamdani Comparison of the Impact of the Atrial Fibrillation Follow-Up Investigation of Rhythm Management Trial on Prescribing Patterns: A Time-Series Analysis Ann. Pharmacother., November 1, 2008; 42(11): 1563 - 1572. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Miller, H. Mogun, D. Azrael, K. Hempstead, and D. H. Solomon Cancer and the Risk of Suicide in Older Americans J. Clin. Oncol., October 10, 2008; 26(29): 4720 - 4724. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Tang, J. Y. Wan, and J. E. Bailey Performance of Comorbidity Measures to Predict Stroke and Death in a Community-Dwelling, Hypertensive Medicaid Population Stroke, July 1, 2008; 39(7): 1938 - 1944. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. S. Adams, C. M. Trinacty, F. Zhang, K. Kleinman, R. W. Grant, J. B. Meigs, S. B. Soumerai, and D. Ross-Degnan Medication Adherence and Racial Differences in A1C Control Diabetes Care, May 1, 2008; 31(5): 916 - 921. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. B. Soumerai, F. Zhang, D. Ross-Degnan, D. E. Ball, R. F. LeCates, M. R. Law, T. E. Hughes, D. Chapman, and A. S. Adams Use Of Atypical Antipsychotic Drugs For Schizophrenia In Maine Medicaid Following A Policy Change Health Aff., May 1, 2008; 27(3): w185 - w195. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. L. Rudolph, M. J. Salow, M. C. Angelini, and R. E. McGlinchey The Anticholinergic Risk Scale and Anticholinergic Adverse Effects in Older Persons Arch Intern Med, March 10, 2008; 168(5): 508 - 513. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. M. Mortensen, M. J. Pugh, L. A. Copeland, M. I. Restrepo, J. E. Cornell, A. Anzueto, and J. A. Pugh Impact of statins and angiotensin-converting enzyme inhibitors on mortality of subjects hospitalised with pneumonia Eur. Respir. J., March 1, 2008; 31(3): 611 - 617. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. L. Lipscombe, T. Gomes, L. E. Levesque, J. E. Hux, D. N. Juurlink, and D. A. Alter Thiazolidinediones and Cardiovascular Outcomes in Older Patients With Diabetes JAMA, December 12, 2007; 298(22): 2634 - 2643. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Zhang and S. B. Soumerai Do Newer Prescription Drugs Pay For Themselves? A Reassessment Of The Evidence Health Aff., May 1, 2007; 26(3): 880 - 886. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. F. Wharam, B. E. Landon, A. A. Galbraith, K. P. Kleinman, S. B. Soumerai, and D. Ross-Degnan Emergency Department Use and Subsequent Hospitalizations Among Members of a High-Deductible Health Plan JAMA, March 14, 2007; 297(10): 1093 - 1102. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Schneeweiss, S. Setoguchi, A. Brookhart, C. Dormuth, and P. S. Wang Risk of death associated with the use of conventional versus atypical antipsychotic drugs among elderly patients Can. Med. Assoc. J., February 27, 2007; 176(5): 627 - 632. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J M Brophy, L E Levesque, and B Zhang The coronary risk of cyclo-oxygenase-2 inhibitors in patients with a previous myocardial infarction Heart, February 1, 2007; 93(2): 189 - 194. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. M. Bell, J. Bajcar, A. S. Bierman, P. Li, M. M. Mamdani, and D. R. Urbach Potentially Unintended Discontinuation of Long-term Medication Use After Elective Surgical Procedures Arch Intern Med, December 11, 2006; 166(22): 2525 - 2531. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Schneider, L. E. Levesque, B. Zhang, T. Hutchinson, and J. M. Brophy Association of Selective and Conventional Nonsteroidal Antiinflammatory Drugs with Acute Renal Failure: A Population-based, Nested Case-Control Analysis Am. J. Epidemiol., November 1, 2006; 164(9): 881 - 889. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. A. Dhalla, M. M. Mamdani, A. E. Simor, A. Kopp, P. A. Rochon, and D. N. Juurlink Are Broad-Spectrum Fluoroquinolones More Likely To Cause Clostridium difficile-Associated Disease? Antimicrob. Agents Chemother., September 1, 2006; 50(9): 3216 - 3219. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. A. Alter, D. T. Ko, A. Newman, and J. V. Tu Factors explaining the under-use of reperfusion therapy among ideal patients with ST-segment elevation myocardial infarction Eur. Heart J., July 1, 2006; 27(13): 1539 - 1549. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. E. Levesque, J. M. Brophy, and B. Zhang Time variations in the risk of myocardial infarction among elderly users of COX-2 inhibitors Can. Med. Assoc. J., May 23, 2006; 174(11): 1563 - 1569. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. N. Juurlink, M. M. Mamdani, A. Kopp, and D. A. Redelmeier The Risk of Suicide With Selective Serotonin Reuptake Inhibitors in the Elderly Am J Psychiatry, May 1, 2006; 163(5): 813 - 821. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. George, T. Vuong, M. J Bailey, D. C. Kong, J. L Marriott, and K. Stewart Development and Validation of the Medication-Based Disease Burden Index Ann. Pharmacother., April 1, 2006; 40(4): 645 - 650. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Y. Park-Wyllie, D. N. Juurlink, A. Kopp, B. R. Shah, T. A. Stukel, C. Stumpo, L. Dresser, D. E. Low, and M. M. Mamdani Outpatient Gatifloxacin Therapy and Dysglycemia in Older Adults N. Engl. J. Med., March 30, 2006; 354(13): 1352 - 1361. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. S. Wang, S. Schneeweiss, J. Avorn, M. A. Fischer, H. Mogun, D. H. Solomon, and M. A. Brookhart Risk of death in elderly users of conventional vs. atypical antipsychotic medications. N. Engl. J. Med., December 1, 2005; 353(22): 2335 - 2341. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. S. Adams, F. Zhang, C. Mah, R. W. Grant, K. Kleinman, J. B. Meigs, and D. Ross-Degnan Race Differences in Long-Term Diabetes Management in an HMO Diabetes Care, December 1, 2005; 28(12): 2844 - 2849. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. R. Benazon, M. M. Mamdani, and J. C. Coyne Trends in the Prescribing of Antidepressants Following Acute Myocardial Infarction, 1993-2002 Psychosom Med, November 1, 2005; 67(6): 916 - 920. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Pepin, L. Valiquette, and B. Cossette Mortality attributable to nosocomial Clostridium difficile-associated disease during an epidemic caused by a hypervirulent strain in Quebec Can. Med. Assoc. J., October 25, 2005; 173(9): 1037 - 1042. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. A. Rochon, T. A. Stukel, K. Sykora, S. Gill, S. Garfinkel, G. M. Anderson, S.-L. T. Normand, M. Mamdani, P. E. Lee, P. Li, et al. Atypical Antipsychotics and Parkinsonism Arch Intern Med, September 12, 2005; 165(16): 1882 - 1888. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. R. Globe, R. Varma, M. Torres, J. Wu, R. Klein, S. P. Azen, and for the Los Angeles Latino Eye Study Group Self-reported Comorbidities and Visual Function in a Population-Based Study: The Los Angeles Latino Eye Study Arch Ophthalmol, June 1, 2005; 123(6): 815 - 821. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. G. Hackam, A. Kopp, and D. A. Redelmeier Prognostic Implications of Warfarin Cessation After Major Trauma: A Population-Based Cohort Analysis Circulation, May 3, 2005; 111(17): 2250 - 2256. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Sturmer, S. Schneeweiss, M. A. Brookhart, K. J. Rothman, J. Avorn, and R. J. Glynn Analytic Strategies to Adjust Confounding using Exposure Propensity Scores and Disease Risk Scores: Nonsteroidal Antiinflammatory Drugs and Short-term Mortality in the Elderly Am. J. Epidemiol., May 1, 2005; 161(9): 891 - 898. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. S. Gill, M. Mamdani, G. Naglie, D. L. Streiner, S. E. Bronskill, A. Kopp, K. I. Shulman, P. E. Lee, and P. A. Rochon A Prescribing Cascade Involving Cholinesterase Inhibitors and Anticholinergic Drugs Arch Intern Med, April 11, 2005; 165(7): 808 - 813. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. E. Levesque, J. M. Brophy, and B. Zhang The Risk for Myocardial Infarction with Cyclooxygenase-2 Inhibitors: A Population Study of Elderly Adults Ann Intern Med, April 5, 2005; 142(7): 481 - 489. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. R. Shah, J. E. Hux, A. Laupacis, B. Zinman, and C. van Walraven Clinical Inertia in Response to Inadequate Glycemic Control: Do specialists differ from primary care physicians? Diabetes Care, March 1, 2005; 28(3): 600 - 606. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. C. McGregor, P. W. Kim, E. N. Perencevich, D. D. Bradham, J. P. Furuno, K. S. Kaye, J. C. Fink, P. Langenberg, M.-C. Roghmann, and A. D. Harris Utility of the Chronic Disease Score and Charlson Comorbidity Index as Comorbidity Measures for Use in Epidemiologic Studies of Antibiotic-resistant Organisms Am. J. Epidemiol., March 1, 2005; 161(5): 483 - 493. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. S Gill, P. A Rochon, N. Herrmann, P. E Lee, K. Sykora, N. Gunraj, S.-L. T Normand, J. H Gurwitz, C. Marras, W. P Wodchis, et al. Atypical antipsychotic drugs and risk of ischaemic stroke: population based retrospective cohort study BMJ, February 26, 2005; 330(7489): 445. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Battistella, M. M. Mamdami, D. N. Juurlink, L. Rabeneck, and A. Laupacis Risk of Upper Gastrointestinal Hemorrhage in Warfarin Users Treated With Nonselective NSAIDs or COX-2 Inhibitors Arch Intern Med, January 24, 2005; 165(2): 189 - 192. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Padwal, M. Mamdani, D. A. Alter, J. E. Hux, D. M. Rothwell, K. Tu, and A. Laupacis Antihypertensive Therapy and Incidence of Type 2 Diabetes in an Elderly Cohort Diabetes Care, October 1, 2004; 27(10): 2458 - 2463. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. J Shalansky, A. R Levy, and A. P Ignaszewski Self-Reported Morisky Score for Identifying Nonadherence with Cardiovascular Medications Ann. Pharmacother., September 1, 2004; 38(9): 1363 - 1368. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Herrmann, M. Mamdani, and K. L. Lanctot Atypical Antipsychotics and Risk of Cerebrovascular Accidents Am J Psychiatry, June 1, 2004; 161(6): 1113 - 1115. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. T. Ko, M. Mamdani, and D. A. Alter Lipid-Lowering Therapy With Statins in High-Risk Elderly Patients: The Treatment-Risk Paradox JAMA, April 21, 2004; 291(15): 1864 - 1870. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. N. Juurlink, M. Mamdani, A. Kopp, A. Laupacis, and D. A. Redelmeier Drug-Drug Interactions Among Elderly Patients Hospitalized for Drug Toxicity JAMA, April 2, 2003; 289(13): 1652 - 1658. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Mamdani, P. Rochon, D. N. Juurlink, G. M. Anderson, A. Kopp, G. Naglie, P. C. Austin, and A. Laupacis Effect of Selective Cyclooxygenase 2 Inhibitors and Naproxen on Short-term Risk of Acute Myocardial Infarction in the Elderly Arch Intern Med, February 24, 2003; 163(4): 481 - 486. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Mamdani, P. A Rochon, D. N Juurlink, A. Kopp, G. M Anderson, G. Naglie, P. C Austin, and A. Laupacis Observational study of upper gastrointestinal haemorrhage in elderly patients given selective cyclo-oxygenase-2 inhibitors or conventional non-steroidal anti-inflammatory drugs BMJ, September 21, 2002; 325(7365): 624 - 624. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Schneeweiss, A. M. Walker, R. J. Glynn, M. Maclure, C. Dormuth, and S. B. Soumerai Outcomes of Reference Pricing for Angiotensin-Converting-Enzyme Inhibitors N. Engl. J. Med., March 14, 2002; 346(11): 822 - 829. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. E. Levesque, J. M. Brophy, and B. Zhang The Risk for Myocardial Infarction with Cyclooxygenase-2 Inhibitors: A Population Study of Elderly Adults Ann Intern Med, April 5, 2005; 142(7): 481 - 489. [Abstract] [Full Text] [PDF]
|
|